Long-lasting antitumor effects provided by radiotherapy combined with the immunocytokine L19-IL2

Research output: Contribution to journalArticleAcademicpeer-review


Recently, we have shown that radiotherapy (RT) combined with L19-IL2 can induce a long-lasting antitumor effect, dependent on ED-B expression and infiltration of cytotoxic T cells. These findings will be translated to a Phase I clinical study (NCT02086721) in patients with oligometastatic solid tumors. See this link for the animation: http://youtu.be/xHbwQuCTkRc.

Original languageEnglish
Pages (from-to)e1021541
Issue number8
Publication statusPublished - Aug 2015

Cite this